Global health progress – The Guardian article series
Through IFPMA’s partnership with The Guardian, informed conversations about the state of global health progress in various areas were carried out with the help of experts, including academia, international actors and industry. The following series presents articles published in The Guardian Labs: The value of medicine in achieving global health progress This was first published on...
Read moreCovid-19 vaccine: when, and for whom?
On 24 July, Thomas Cueni, IFPMA Director General, joined Imogen Foulkes for the Inside Geneva podcast on Swiss Info, to talk about the development, production and eventual distribution of COVID-19 vaccines. Their discussion highlighted the importance of broad-based collaborative efforts among all stakeholders as well as the vital necessity of leaving no one behind and...
Read more#TeamVaccines is all of us
This blog was originally posted on Pharma Boardroom on 23 February 2021 The story of COVID-19 vaccines is one of incredible collaboration. Never before has there been such an effort on a mass scale to solve a global health crisis. We’ve seen a decade of normal vaccine development compressed into just ten months. From the...
Read moreLearning from COVID-19 – from panic to preparedness
This blog was originally published on Media Planet Infectious Disease campaign on 24 March 2021. Whilst we are still in the midst of COVID-19, the worst pandemic since 1918 which is affecting every part of our lives, we can draw some lessons that will allow us to be better prepared for the future. The first...
Read moreMomentum of COVID-19 vaccine manufacturing scale up sufficient for step change in distribution
Last week we convened another media briefing on the biopharmaceutical industry’s efforts to ramp up manufacturing capacity for COVID-19 vaccines, treatments and supplies. We were joined by CEOs and executives from Pfizer, Roche, Merck, Johnson & Johnson, whose 3 main take-aways I would like to share with you. The historic COVID-19 manufacturing scale up has...
Read moreMarie-Chantal Umunyana speaks to the strength of safe spaces in healthcare for women
Marie-Chantal Umunyana joins IFPMA and HYPER‘s virtual discussion on: “The Importance of Diversity & Equal Opportunities in a Healthy R&D Environment”
Read moreStepping up research and innovation to beat TB
In a year dedicated to progressing the fight against tuberculosis — with the upcoming United Nations High-level Political Meeting — the evidence casts a bleak outlook. But there's hope.
Read more
Why confidence in vaccines matters today and in the future?
During the pandemic, vaccines were at the top of the news agenda and at the forefront of people’s minds like never before. Scientists were celebrated on magazine covers, and vaccine makers became household names. The largest vaccination campaign in history helped to save millions of lives, protecting people from serious illness and helping our world...
Read more
The importance of a thriving innovation ecosystem: A look at how Hepatitis C was identified and cured
Innovation often comes in waves, set in motion by science. Such was the case when a cure was found for hepatitis C virus (HCV). It was followed by others in quick succession, giving us multiple tools to successfully tackle the disease. The story of HCV shows us what a thriving innovation ecosystem can achieve –...
Read more
Accelerating antiviral development is central to pandemic preparedness
As leaders and health experts from across the world gather in New York for the UN General Assembly, they are considering three issues that are critical to the future of global health and global health security. As world leaders discuss political declarations on ending tuberculosis (TB), delivering universal health coverage (UHC) and strengthening pandemic prevention, preparedness...
Read more